Evaluation of Ureteral Patency in the Post-indigo Carmine Era

NCT02677623 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Ureteral Patency

Interventions

DRUG: Pyridium
DRUG: Sodium Fluorescein
DRUG: Mannitol
OTHER: Normal Saline

Sponsor

Columbia University